Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance.

Abstract:

:Pancreatic cancer, one of the deadliest human malignancies, is almost invariably associated with the presence of an oncogenic form of Kras. Mice expressing oncogenic Kras in the pancreas recapitulate the stepwise progression of the human disease. The inflammatory cytokine interleukin (IL)-6 is often expressed by multiple cell types within the tumor microenvironment. Here, we show that IL-6 is required for the maintenance and progression of pancreatic cancer precursor lesions. In fact, the lack of IL-6 completely ablates cancer progression even in presence of oncogenic Kras. Mechanistically, we show that IL-6 synergizes with oncogenic Kras to activate the reactive oxygen species detoxification program downstream of the mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) signaling cascade. In addition, IL-6 regulates the inflammatory microenvironment of pancreatic cancer throughout its progression, providing several signals that are essential for carcinogenesis. Thus, IL-6 emerges as a key player at all stages of pancreatic carcinogenesis and a potential therapeutic target.

journal_name

Cancer Res

journal_title

Cancer research

authors

Zhang Y,Yan W,Collins MA,Bednar F,Rakshit S,Zetter BR,Stanger BZ,Chung I,Rhim AD,di Magliano MP

doi

10.1158/0008-5472.CAN-13-1558-T

subject

Has Abstract

pub_date

2013-10-15 00:00:00

pages

6359-74

issue

20

eissn

0008-5472

issn

1538-7445

pii

0008-5472.CAN-13-1558-T

journal_volume

73

pub_type

杂志文章
  • A Deep Learning Framework Identifies Pathogenic Noncoding Somatic Mutations from Personal Prostate Cancer Genomes.

    abstract::Our understanding of noncoding mutations in cancer genomes has been derived primarily from mutational recurrence analysis by aggregating clinical samples on a large scale. These cohort-based approaches cannot directly identify individual pathogenic noncoding mutations from personal cancer genomes. Therefore, although ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-20-1791

    authors: Wang C,Li J

    更新日期:2020-11-01 00:00:00

  • Dehydroepiandrosterone can inhibit the proliferation of myeloma cells and the interleukin-6 production of bone marrow mononuclear cells from patients with myeloma.

    abstract::The serum levels of an adrenal sex hormone, dehydroepiandrosterone sulfate (DHEA-S), are significantly more decreased in human myelomas compared with the reduction brought by physiologic decline with age. In order to clarify the effect of DHEA on myeloma cells, we investigated whether DHEA and DHEA-S could inhibit int...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-3079

    authors: Liu S,Ishikawa H,Li FJ,Ma Z,Otsuyama K,Asaoku H,Abroun S,Zheng X,Tsuyama N,Obata M,Kawano MM

    更新日期:2005-03-15 00:00:00

  • Isolation of prostatic acid phosphatase-binding immunoglobulin G from human sera and its potential for use as a tumor-localizing reagent.

    abstract::A human immunoglobulin that binds prostatic acid phosphatases (PAP) was isolated from the serum of normal individuals by affinity chromatography using a PAP-Sepharose solid adsorbent. The yield of isolated protein, termed PAP-binding globulin (PAPBG), ranged from 4.7 to 16.3 microgram/ml serum. As shown by immunoelect...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Papsidero LD,Wojcieszyn JW,Horoszewicz JS,Leong SS,Murphy GP,Chu TM

    更新日期:1980-08-01 00:00:00

  • VEGF exerts an angiogenesis-independent function in cancer cells to promote their malignant progression.

    abstract::VEGF/vascular permeability factor (VEGF/VPF or VEGF-A) is a pivotal driver of cancer angiogenesis that is a central therapeutic target in the treatment of malignancy. However, little work has been devoted to investigating functions of VEGF that are independent of its proangiogenic activity. Here, we report that VEGF p...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-11-4058

    authors: Cao Y,E G,Wang E,Pal K,Dutta SK,Bar-Sagi D,Mukhopadhyay D

    更新日期:2012-08-15 00:00:00

  • The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer.

    abstract::Prostate cancer (PCa) is the most common male cancer in the United States. A major challenge that remains is to predict the clinical outcome in managing PCa patients. The prolyl isomerase Pin1 has been shown to be overexpressed in some human cancer tissues and thought to be an important player in several oncogenic pat...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ayala G,Wang D,Wulf G,Frolov A,Li R,Sowadski J,Wheeler TM,Lu KP,Bao L

    更新日期:2003-10-01 00:00:00

  • Oncogenic transformation of C3H/10T1/2 clone 8 mouse embryo cells by halogenated pyrimidine nucleosides.

    abstract::Oncogenic transformation has been induced in vitro in the C3H/10T1/2 clone 8 line of mouse cells by exposure to 5-fluoro-2'-deoxyuridine (FUdR) or 5-fluorouracil. This transformation is both dose and time dependent and can be markedly decreased by simultaneous exposure of the cells to thymidine. The transformation ind...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Jones PA,Benedict WF,Baker MS,Mondal S,Rapp U,Heidelberger C

    更新日期:1976-01-01 00:00:00

  • Intrathecal 4-hydroperoxycyclophosphamide: neurotoxicity, cerebrospinal fluid pharmacokinetics, and antitumor activity in a rabbit model of VX2 leptomeningeal carcinomatosis.

    abstract::Dissemination of tumor to the leptomeninges and cerebrospinal fluid represents a common pattern of metastasis for many cancers; however, few chemotherapeutic agents are available for intrathecal (i.t.) use and treatment results are often poor. We studied the neurotoxicity and pharmacokinetics of i.t. 4-hydroperoxycycl...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Phillips PC,Than TT,Cork LC,Hilton J,Carson BS,Colvin OM,Grochow LB

    更新日期:1992-11-15 00:00:00

  • Upregulation of E3 Ubiquitin Ligase CBLC Enhances EGFR Dysregulation and Signaling in Lung Adenocarcinoma.

    abstract::CBLC (CBL proto-oncogene c) belongs to the CBL protein family, which has E3 ubiquitin ligase activity toward activated receptor tyrosine kinases. CBLC is frequently upregulated in non-small cell lung cancer (NSCLC), yet very little is known about the functions of CBLC in tumorigenesis. Here we show that CBLC is an epi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-17-3858

    authors: Hong SY,Kao YR,Lee TC,Wu CW

    更新日期:2018-09-01 00:00:00

  • Comparison of the cytotoxic effects of merocyanine-540 on leukemic cells and normal human bone marrow.

    abstract::Various chemical compounds have been described to induce photosensitization of tumor cells resulting in cell death. We studied the effect of merocyanine-540 (MC-540) on both leukemic and normal bone marrow (BM) cells. Acute promyelocytic leukemia (HL-60) and common acute lymphoblastic leukemia antigen-positive non-T, ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Atzpodien J,Gulati SC,Clarkson BD

    更新日期:1986-10-01 00:00:00

  • CpG-A and B oligodeoxynucleotides enhance the efficacy of antibody therapy by activating different effector cell populations.

    abstract::Immunostimulatory CpG oligodeoxynucleotides (ODNs) can enhance the therapeutic effect of monoclonal antibodies (mAbs) by enhancing antibody-dependent cell-mediated cytotoxicity (ADCC). Distinct classes of CpG ODNs have been found recently to stimulate different effector cell populations. We used murine cancer models t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: van Ojik HH,Bevaart L,Dahle CE,Bakker A,Jansen MJ,van Vugt MJ,van de Winkel JG,Weiner GJ

    更新日期:2003-09-01 00:00:00

  • Chemotherapy and chemosensitization of transgenic mice which express the human multidrug resistance gene in bone marrow: efficacy, potency, and toxicity.

    abstract::A common form of multidrug resistance in human cancer results from expression of the MDR1 gene which encodes a plasma membrane energy-dependent multidrug efflux pump. We have engineered transgenic mice which express this multidrug transporter in their bone marrow cells and demonstrated that peripheral WBC of these ani...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Mickisch GH,Licht T,Merlino GT,Gottesman MM,Pastan I

    更新日期:1991-10-01 00:00:00

  • Investigation of Optical Coherence Microelastography as a Method to Visualize Cancers in Human Breast Tissue.

    abstract::An accurate intraoperative identification of malignant tissue is a challenge in the surgical management of breast cancer. Imaging techniques that help address this challenge could contribute to more complete and accurate tumor excision, and thereby help reduce the current high reexcision rates without resorting to the...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-3694

    authors: Kennedy BF,McLaughlin RA,Kennedy KM,Chin L,Wijesinghe P,Curatolo A,Tien A,Ronald M,Latham B,Saunders CM,Sampson DD

    更新日期:2015-08-15 00:00:00

  • Role of active oxygen species in the photodestruction of microsomal cytochrome P-450 and associated monooxygenases by hematoporphyrin derivative in rats.

    abstract::The cytochrome P-450 in hepatic microsomes prepared from rats pretreated with hematoporphyrin derivative was shown to be rapidly destroyed in the presence of long-wave ultraviolet light. The photocatalytic destruction of the heme-protein was dependent on both the dose of ultraviolet light and of hematoporphyrin deriva...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Das M,Dixit R,Mukhtar H,Bickers DR

    更新日期:1985-02-01 00:00:00

  • Hepatocyte nuclear factor-4alpha promotes gut neoplasia in mice and protects against the production of reactive oxygen species.

    abstract::Hepatocyte nuclear factor-4α (Hnf4α) is a transcription factor that controls epithelial cell polarity and morphogenesis. Hnf4α conditional deletion during postnatal development has minor effects on intestinal epithelium integrity but promotes activation of the Wnt/β-catenin pathway without causing tumorigenesis. Here,...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-1697

    authors: Darsigny M,Babeu JP,Seidman EG,Gendron FP,Levy E,Carrier J,Perreault N,Boudreau F

    更新日期:2010-11-15 00:00:00

  • DNA replication licensing factor minichromosome maintenance deficient 5 rescues p53-mediated growth arrest.

    abstract::Inactivation of p53 signaling by mutation of p53 itself or abrogation of its normal function by other transfactors, such as MDM2, is a key event in the development of most human cancers. To identify novel regulators of p53, we have used a phenotype-based selection in which a total cDNA library in a retroviral vector h...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-2835

    authors: Agarwal MK,Ruhul Amin AR,Agarwal ML

    更新日期:2007-01-01 00:00:00

  • CXCR4 enhances adhesion of B16 tumor cells to endothelial cells in vitro and in vivo via beta(1) integrin.

    abstract::The chemokine receptor, CXCR4, is expressed by human melanomas, and its ligand, CXCL12, is frequently produced at sites of melanoma metastasis. Herein, we examine CXCR4-enhanced binding of B16 murine melanoma cells to endothelial cells (ECs) and recombinant adhesion molecules in vitro to determine the role of tumor- a...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Cardones AR,Murakami T,Hwang ST

    更新日期:2003-10-15 00:00:00

  • Proteomic portrait of human breast cancer progression identifies novel prognostic markers.

    abstract::Breast cancer is the second leading cause of cancer death for women in the United States. Of the different subtypes, estrogen receptor-negative (ER(-)) tumors, which are ErbB2+ or triple-negative, carry a relatively poor prognosis. In this study, we used system-wide analysis of breast cancer proteomes to identify prot...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-11-3711

    authors: Geiger T,Madden SF,Gallagher WM,Cox J,Mann M

    更新日期:2012-05-01 00:00:00

  • Evaluation of the potential role of class II histocompatibility antigen HLA-DR in platelet/tumor cell interaction.

    abstract::It has been reported that HLA-DR is a potent inducer of thrombin generation. Human colorectal cells (GEO, WiDr, DLD-1, and MIP) that lack the constitutive expression of HLA-DR cause platelet aggregation through a thrombin-dependent mechanism. Treatment with recombinant human gamma-interferon induced the expression of ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ferroni P,Guadagni F,Spila A,Martini F,Gazzaniga PP

    更新日期:1994-02-01 00:00:00

  • In silico modeling and in vivo efficacy of cancer-preventive vaccinations.

    abstract::Cancer vaccine feasibility would benefit from reducing the number and duration of vaccinations without diminishing efficacy. However, the duration of in vivo studies and the huge number of possible variations in vaccination protocols have discouraged their optimization. In this study, we employed an established mouse ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-0701

    authors: Palladini A,Nicoletti G,Pappalardo F,Murgo A,Grosso V,Stivani V,Ianzano ML,Antognoli A,Croci S,Landuzzi L,De Giovanni C,Nanni P,Motta S,Lollini PL

    更新日期:2010-10-15 00:00:00

  • DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells.

    abstract::Increased levels of DNA fragments have frequently been found in the blood plasma of cancer patients. Published data suggest that only a fraction of the DNA in blood plasma is derived from cancer cells. However, it is not known how much of the circulating DNA is from cancer or from noncancer cells. By quantitative meth...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Jahr S,Hentze H,Englisch S,Hardt D,Fackelmayer FO,Hesch RD,Knippers R

    更新日期:2001-02-15 00:00:00

  • Establishment of a human megakaryoblastic cell line (T-33) from chronic myelogenous leukemia in megakaryoblastic crisis.

    abstract::A megakaryoblastic cell line, termed T-33, was established from the peripheral blood of a patient with Philadelphia chromosome-positive chronic myelogenous leukemia in megakaryoblastic crisis. T-33 cells have been maintained in RPMI 1640 medium containing 10% fetal calf serum in a single cell suspension with a doublin...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Tange T,Nakahara K,Mitani K,Yamasaki I,Yasuda H,Tanaka F,Mizuguchi M,Oda H,Yatomi Y,Takanashi R

    更新日期:1988-11-01 00:00:00

  • Numerical variation of dark cells in normal and chemically induced hyperplastic epidermis with age of animal and efficiency of tumor promoter.

    abstract::The percentages of dark keratinocytes was quantitatively assessed in normal epidermis of Sencar mice before and after birth and in adult epidermis after topical application of several compounds of varying promoting efficiency. The percentage of dark keratinocytes reached a maximum at the 19th day of gestation (approxi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Klein-Szanto AJ,Slaga TJ

    更新日期:1981-11-01 00:00:00

  • Selective in vivo imaging of syngeneic, spontaneous, and xenograft tumors using a novel tumor cell-specific hsp70 peptide-based probe.

    abstract::Although in vivo targeting of tumors using fluorescently labeled probes has greatly gained in importance over the last few years, most of the clinically applied reagents lack tumor cell specificity. Our novel tumor cell-penetrating peptide-based probe (TPP) recognizes an epitope of Hsp70 that is exclusively present on...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-0413

    authors: Stangl S,Varga J,Freysoldt B,Trajkovic-Arsic M,Siveke JT,Greten FR,Ntziachristos V,Multhoff G

    更新日期:2014-12-01 00:00:00

  • Enhancement of cytolytic T lymphocyte precursor frequency in melanoma patients following immunization with the MAGE-1 peptide loaded antigen presenting cell-based vaccine.

    abstract::Identification of human melanoma-associated peptide antigens for CTLs has opened unprecedented opportunities for active specific immunotherapy for melanoma with synthetic peptide. We have shown that immunization with a MAGE-1 gene encoded nonapeptide (EADPT-GHSY)-pulsed autologous antigen presenting cell-based vaccine...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hu X,Chakraborty NG,Sporn JR,Kurtzman SH,Ergin MT,Mukherji B

    更新日期:1996-06-01 00:00:00

  • Src stimulates fibroblast growth factor receptor-2 shedding by an ADAM15 splice variant linked to breast cancer.

    abstract::ADAMs (a disintegrin and metalloproteinase) have important roles in development and diseases such as cancer. Previously, an ADAM15 splice variant (ADAM15B), which contains an inserted cytoplasmic Src-binding site, was linked to clinical aggressiveness in breast cancer, yet little was known about how this splice varian...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-4766

    authors: Maretzky T,Le Gall SM,Worpenberg-Pietruk S,Eder J,Overall CM,Huang XY,Poghosyan Z,Edwards DR,Blobel CP

    更新日期:2009-06-01 00:00:00

  • Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment.

    abstract::We have investigated the ability of tamoxifen to regulate members of the transforming growth factor beta (TGF-beta) family in human breast cancers in vivo. Using immunohistochemical techniques, we find that 3 months of tamoxifen treatment causes a consistent induction of extracellular TGF-beta 1 in breast cancer biops...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Butta A,MacLennan K,Flanders KC,Sacks NP,Smith I,McKinna A,Dowsett M,Wakefield LM,Sporn MB,Baum M

    更新日期:1992-08-01 00:00:00

  • Platelet granule secretion continuously prevents intratumor hemorrhage.

    abstract::Cancer is associated with a prothrombogenic state capable of platelet activation. Platelets, on the other hand, can support angiogenesis, a process involved in the progression of tumor growth and metastasis. However, it is unclear whether platelet/tumor interactions substantially contribute to tumor physiology. We inv...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-0718

    authors: Ho-Tin-Noé B,Goerge T,Cifuni SM,Duerschmied D,Wagner DD

    更新日期:2008-08-15 00:00:00

  • Factors affecting the expression of carcinoembryonic antigen at the surface of cultured human colon carcinoma cells.

    abstract::Factors affecting the expression of carcinoembryonic antigen (CEA) at the surface of in vitro human colon carcinoma cells were determined using 125I-labeled antibodies. Binding of specific anti-CEA antibodies resulted in polar redistribution of CEA, followed by endocytosis of most of the CEA-anti-CEA complexes. These ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Rosenthal KL,Tompkins WA,Rawls WE

    更新日期:1980-12-01 00:00:00

  • Important role of serotonin in the antitumor effects of recombinant human tumor necrosis factor-alpha in mice.

    abstract::The possible involvement of chemical mediator(s) in the induction of the antitumor effects of recombinant human tumor necrosis factor-alpha (rTNF-alpha) on Meth A fibrosarcoma (Meth A) in mice was studied. On day 7 after intradermal implantation of Meth A in mice, rTNF-alpha caused tumor necrosis and inhibited the tum...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Manda T,Nishigaki F,Mori J,Shimomura K

    更新日期:1988-08-01 00:00:00

  • Selective killing of methotrexate-resistant cells carrying amplified dihydrofolate reductase genes.

    abstract::A method for the selective killing of methotrexate (MTX)-resistant cells has been developed. The selection is based on the incorporation of tritiated deoxyuridine into the DNA of MTX-resistant cells but not normal MTX-sensitive cells in the presence of the drug. A Chinese hamster ovary cell mutant that overproduces di...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Urlaub G,Landzberg M,Chasin LA

    更新日期:1981-05-01 00:00:00